Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment
Clinical trial NCT02550106 · COMPLETED
Trial details
- NCT number
- NCT02550106
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-22
- Primary completion
- 2016-01-11
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.